| Net loss | -8.43M |
| Depreciation and amortization | 430.54K |
| Stock based compensation | 1.2M |
| Provision for inventory obsolescence | 253.05K |
| Provision for doubtful accounts receivable | -5K |
| Deferred tax (benefit) | |
| Accounts receivable - trade | 856.39K |
| Accounts receivable - other | -147.05K |
| Inventories | -3.56K |
| Prepaid expenses | -47.75K |
| Other assets | 24.53K |
| Accounts payable | 403.61K |
| Accrued expenses | |
| Income taxes payable | |
| Customer deposits | |
| Net cash (used in) provided by operating activities | -4.73M |
| Purchases of furniture, fixtures and equipment | -284.64K |
| Additions to intangible assets | -89.26K |
| Net cash used in investing activities | -373.91K |
| Proceeds from issuance of subordinated note payable | |
| Change in line of credit | |
| Deferred issuance costs for subordinated note payable | 0 |
| Proceeds from exercise of stock options and warrants | |
| Excess in tax benefits related to stock-based compensation | |
| Net cash provided by financing activities | -7.86K |
| Net (decrease) increase in cash and cash equivalents | -5.11M |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |
| Cash payments for interest | 2.43K |
| Cash payments for income taxes | |
| Restricted common stock grant | |
| Common stock surrendered as consideration for exercise of stock options | |
| Transfer of demonstration equipment | |